The drugs are listed in alphabetical order. Adalimumab-Adbm injection: Boehringer Ingelheim Pharmaceuticals discontinued two presentations of Cyltezo, its biosimilar to Humira. The injectable ...
Abbvie said on Friday it would record a charge of about $3.5 billion related to its experimental schizophrenia drug, ...
"Our study suggests that vedolizumab is a viable option for induction and long-term maintenance therapy in children with IBD, ...
Korean drugmakers hold over 50% market share in the 6 best-selling biosimilar markets, 2 companies sign exclusive licensing ...
Graypoint LLC lessened its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 7.1% during the 4th quarter, according ...
LVM Capital Management Ltd. MI lifted its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 4.4% in the 4th quarter, ...
These three companies are healthcare leaders. They treat their shareholders well and offer promising growth prospects at ...